期刊文献+

^(99)Tc^m-DTPA-Gd的制备及其生物学分布 被引量:1

Preparation and Biodistribution of ^(99)Tc^m-DTPA-Gd
下载PDF
导出
摘要 应用99Tcm标记顺磁对比剂Gd-DTPA并研究其生物学分布特性。99Tcm在氯化亚锡还原下一步法标记Gd-DTPA,采用薄层纸层析法(TLC)分析标记率大于98%,室温放置6 h内放化纯稳定。三氯乙酸沉淀法测得99Tcm-DTPA-Gd在家兔血浆中的蛋白结合率为(3.80±0.25)%。正常昆明小鼠体内分布实验显示,注射99Tcm-DTPA-Gd后1 min血液的放射性摄取为(14.79±9.77)%ID/g,肾脏的摄取为(26.02±8.50)%ID/g;心、肝、脾和肺有少量分布,脑组织分布最少(<1%ID/g);注射99Tcm-DTPA-Gd 30~60 min后多数脏器的滞留小于1%ID/g。正常成年家兔注射99Tcm-DTPA-Gd后采用肾动态显像模式观察60 min内的分布和排泄,显示99Tcm-DTPA-Gd主要经肾脏排泄,摄取高峰时间约为5~10 min,半排时间约为10~20 min,其它脏器无特异性滞留。 To observe the biologic characteristics of Gd-DTPA labeled with 99Tcm,the labeled compounds were prepared by reducing 99Tcm in the presence of Gd-DTPA with stannous chloride.The labeling efficiency was measured by TLC(〉98%,and stable at room temperature within 6 h).The plasma protein binding rate measured by the trichloroacetic acid method is(3.80±0.25)%.The bio-distribution in mice was observed by the blood sampling and other major organs that were taken out from mice at 1,5,10,15,30,and 60 min after intravenous injection of labeled compounds.The percentage of the injected dose per gram of tissues(%ID/g) of the blood and kidney are the highest level at 1 min after injection of 99Tcm-DTPA-Gd.They are(14.79±9.77)%ID/g and(26.02±8.50)%ID/g,respectively.Heart,liver,spleen and lung have a little distribution of radiopharmaceuticals,and brain has the lowest level uptake less than 1%.The deposition of 99Tcm-DTPA-Gd in other major organs was less than 1% at 30-60 min after injection.Renal dynamic scintigraphy in rabbits are administrated,and show that 99Tcm-DTPA-Gd is quickly excreted by kidney,and the time to peak is about 5-10 min,the half time of clearance is about 10-20 min.The animal experiments in vivo and in vitro show that 99Tcm-DTPA-Gd and 99Tcm-DTPA have the qualitatively similar biodistribution and excretion.99Tcm labeled Gd-DTPA may be a significant way not only to study its bio-distribution but also to directly observe its distribution and excretion by renal dynamic scintigraphy.
出处 《核化学与放射化学》 CAS CSCD 北大核心 2010年第3期177-183,共7页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(30970858) 2008年四川省医学重点学科建设项目(2008-17) 四川省杰出青年学科带头人资助项目(2008-46-386)
关键词 GD-DTPA 肾小球滤过率 99Tcm 同位素标记 生物学分布 Gd-DTPA GFR 99Tcm isotope labeling biodistribution
  • 相关文献

参考文献10

  • 1Russell C D,Rowell K,Scott J W.Quality Control of Technetium-99m DTPA:Correlation of Analytic Tests With in Vivo Protein Binding in Man[J].J Nucl Med,1986,27(4):560-562.
  • 2Abou El-Ghar M E,Shokeir A A,Refaie H F,et al.MRI in Patients With Chronic Obstructive Uropathy and Compromised Renal Function:A Sole Method for Morphological and Functional Assessment[J].Br J Radiol,2008,81(968):624-629.
  • 3Choyke P L,Austin H A,Frank J A,et al.Hydrated Clearance of Gadolinium-DTPA as a Measurement of Glomerular Filtration Rate[J].Kidney Int,1992,41(6):1 595-1 598.
  • 4Weinmann H J,Brasch R C,Press W R,et al.Characteristics of Gadolinium-DTPA Complex.A Potential NMR Contrast Agent[J].Am J Roentgenol,1984,142(3):619-624.
  • 5Prato F S,Wisenberg G,Marshall T P,et al.Comparison of the Biodistribution of Gadolinium-153 DTPA and Technetium-99m DTPA in Rats[J].J Nucl Med,1988,29(10):1 683-1 687.
  • 6李明,林祥通,程伟,管一晖,施孝金,郑传钧.^(153)Gd—DTPA的合成及其在小鼠体内分布的实验研究[J].核技术,1995,18(5):278-281. 被引量:2
  • 7Russell C D,Bischoff P G,Rowell K L,et al.Quality Control of Tc-99m DTPA for Measurement of Glomerular Filtration,Concise Communication[J].J Nucl Med,1983,24(8):722-727.
  • 8Assadi M,Eftekhari M,Hozhabrosadati M,et al.Comparison of Methods for Determination of Glomerular Filtration Rate:Low and High-Dose Tc-99m-DTPA Renography,Predicted Creatinine Clearance Method,and Plasma Sample Method[J].Int Urol Nephrol,2008,40(4):1 059-1 065.
  • 9Arheden H,Saeed M,Higgins C B,et al.Measurement of the Distribution Volume of Gadopentetate Dimeglumine at Echo-Planar MR Imaging to Quantify Myocardial Infarction,Comparison With 99mTc-DTPA Autoradiography in Rats[J].Radiology,1999,211(3):698-708.
  • 10Lee S,Chen X.Dual-Modality Probes for in Vivo Molecular Imaging[J].Mol Imaging,2009,8(2),87-100.

二级参考文献1

共引文献1

同被引文献7

  • 1Townsend DW.Dual-modality imaging:combining anatomy and function[J].J Nucl Med,2008,49(6):938-955.
  • 2Hasegawa BH,Iwata K,Wong KH,et al.Dual-modality imaging of function and physiology[J].Acad Radiol,2002,9(11):1305-1321.
  • 3Cho ZH,Son YD,Kim HK,et al.A fusion PET-MRI system with a high-resolution research tomography-PET and ultra-high field 7.0T-MRI for the molecular-genetic imaging of the brain[J].Proteomics,2008,8(6):1302-1323.
  • 4Choi JS,Park JC,Nah H,et al.A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging[J].Angew Chem Int Ed Engl,2008,47(7):6259-6262.
  • 5Lee HY,Li Z,Chen K,et al.PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic(RGD)-conjugated radiolabled iron oxide nanoparticles[J].J Nucl Med,2008,49(8):1371-1379.
  • 6Kristof K,Tatjana N,Sophie L,et al.Potential MRI Contrast Agents Based on Micellar Incorporation of Amphiphilic Bis(alkylamide) Derivatives of[(Gd-DTPA)(H2O)] 2-[J].Eur J Inorg Chem,2003,16(9):3021-3027.
  • 7丁志凌,陈跃,孙媛媛,张伟,黄占文,张莉.Gd-DTPA-Dimeglumine的^(99)Tc^m标记及其生物学特性[J].同位素,2009,22(3):149-155. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部